2024-12-14 - Analysis Report
## Chevron Corp (CVX) Stock Review

**1. Performance Comparison & Divergence:**

Chevron Corp (CVX), an integrated energy company engaged in exploration, production, and refining of oil and natural gas, has underperformed the S&P 500 (VOO) significantly.  The cumulative return of CVX (69.61%) is 51.3 percentage points lower than VOO (120.91%) as of the last data point.  This places its relative divergence at the 19.1st percentile based on historical data (max: 57.8%, min: -77.0%).  The provided Alpha values consistently near zero indicate that CVX's performance has largely tracked the market, lacking significant outperformance.  Beta is not provided.

**2. Recent Price Movement:**

* **Closing Price:** $153.87
* **5-Day Moving Average:** $155.77
* **20-Day Moving Average:** $159.41
* **60-Day Moving Average:** $152.75

The stock is currently trading below its 5-day, 20-day, and 60-day moving averages, suggesting a bearish short-term trend.  The close price of 153.89 is not significantly different from the closing price to trigger a 급반등(rapid rebound) or 급하락 (rapid decline) label.

**3. Technical Indicators & Expected Return:**

* **RSI:** 27.76 (suggests oversold conditions)
* **PPO:** -0.75 (indicates bearish momentum)
* **Recent Relative Divergence:** -0.1 (short-term downward trend)
* **Expected Return:** 0.0% (No significant long-term (2+ years) outperformance over the S&P 500 is predicted based on the provided information.)

The low RSI and negative PPO values, combined with the negative relative divergence, reinforce the bearish short-term outlook.  The expected return of 0% suggests that long-term returns are unlikely to significantly outperform the S&P 500.

**4. Recent Earnings Analysis:**

The latest quarterly earnings data shows a mixed picture:

* **Revenue:** Fluctuated slightly quarter over quarter, with no clear upward or downward trend evident.  There were minor decreases between Q1 and Q2 of 2024 and between Q2 and Q3 of 2024.  There was a notable increase in revenue between Q3 2023 and Q4 2023, which reversed in Q1 2024.  This lack of a consistent upward trend warrants further investigation.
* **EPS:** Showed some volatility.  The EPS decreased in Q2 2024 compared to Q1 2024 and in Q3 2024 compared to Q2 2024. A significant increase was observed between Q4 2023 and Q1 2024.  Overall, there's no consistent upward or downward trend in EPS.  This volatility also warrants further investigation.
* **Comparison with Expectations:**  No information on earnings expectations is provided, preventing a beat/miss analysis.

**5. Financial Information Analysis:**

* **Revenue and Profitability:** Revenue shows some volatility, and profit margins have fluctuated, declining in the most recent quarter. This might indicate a softening market or efficiency challenges.
* **Capital and Profitability:** Equity decreased slightly over the past year. ROE is highly volatile, reaching highs of above 3% but falling as low as 1.40%.  This inconsistency is a key factor requiring further examination.

**6. News and Recent Issues:**

No specific news or recent market outlook/analyst opinions are provided, hindering a complete assessment of current market sentiment.

**7. Overall Analysis:**

CVX has underperformed the S&P 500 significantly over the period considered. Technical indicators suggest a short-term bearish trend, and recent earnings data reveal inconsistent revenue and EPS performance.  The lack of information on market sentiment and expected returns limits further analysis.  The high volatility in ROE and the lack of a consistent upward trend in both revenue and EPS warrants more in-depth financial analysis to uncover the root causes.  Further investigation is needed to determine whether the current undervaluation presents a buying opportunity. More data (specifically regarding analyst expectations, market sentiment, and longer-term historical data) is crucial for a complete and accurate assessment.

**8. Disclaimer:** This analysis is based solely on the provided data. It is not financial advice and should not be considered a recommendation to buy or sell CVX stock.  Always conduct thorough research and consult with a qualified financial advisor before making any investment decisions.
